Overton, Matthew
Culton, Donna
Article History
First Online: 5 November 2018
Compliance with Ethical Standards
:
: Donna Culton is the primary investigator on a clinical trial for pemphigus, which is not mentioned in the manuscript, and reports receiving personal fees for serving on the board for Genetech, which makes rituximab. Matthew Overton declares no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.